Carregant...

Genital tenofovir concentrations correlate with protection against HIV infection in the CAPRISA 004 trial: Importance of adherence for microbicide effectiveness

OBJECTIVE: The CAPRISA 004 trial showed that coitally-dosed tenofovir 1% gel reduced HIV acquisition by 39% overall and 54% when used consistently. The objective of this analysis was to ascertain its pharmacokinetic-pharmacodynamic relationship to protection against HIV acquisition. DESIGN: Genital...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Acquir Immune Defic Syndr
Autors principals: Kashuba, Angela DM, Gengiah, Tanuja N, Werner, Lise, Yang, Kuo-Hsiung, White, Nicole R, Karim, Quarraisha Abdool, Abdool Karim, Salim S.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4505741/
https://ncbi.nlm.nih.gov/pubmed/26181703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000607
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!